These reported benefits on liver function may be due to glucose-lowering and weight loss effects promoted by SGLT2 inhibitors, and may be independent of glycemic control and/or weight loss [48, 49], such as though improvement of insulin resistance, reduction of inflammatory markers and decrease in oxidative stress [31, 32]. Here, SLC5A2 is linked to Insulin resistance.